Roundtable Discussion: Examining the Patient Response During Trials to Prove the Clinical Benefit & Improve Patient Selection
Time: 2:30 pm
day: Conference Day One
Details:
- Scrutinizing patient response throughout treatment by following TGF-β biomarkers to improve later clinical selection
- Assessing the tumor microenvironment pre- and post-TGF-β targeted therapies to prove clinical efficacy
- Employing biomarkers to find clinical efficacy of TGF-β directed therapies
